Erzsébet Ladányi
Fresenius Medical Care
13 Papers
77 Citations
Erzsébet Ladányi is an academic researcher from Fresenius Medical Care. The author has contributed to research in topics: Dialysis & Medicine. The author has an hindex of 7, co-authored 13 publications.
Chat about Author
Papers
On-Line Haemodiafiltration versus Haemodialysis: Stable Haematocrit with Less Erythropoietin and Improvement of Other Relevant Blood Parameters
Lajos Vaslaki,Lajos Major,Klara Berta,Andras Karatson,Mihay Misz,Ferenc Pethoe,Erzsébet Ladányi,Bertalan Fodor,Günter Stein,Monika Pischetsrieder,Thomas Zima,Ralf Wojke,Adelheid Gauly,Jutta Passlick-Deetjen +13 more
TL;DR: No benefit regarding cardiovascular stability for oH DF was found, but oHDF could well offer a potential benefit regarding anaemia correction, inflammation, oxidative stress, lipid profiles, and calcium-phosphate product.
Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration.
Lajos Vaslaki,A. Karátson,P. Vörös,Lajos Major,F. Pethö,Erzsébet Ladányi,Christoph Weber,R Mitteregger,Dieter Falkenhagen +8 more
TL;DR: On-line HDF treatment can routinely be provided with ultra-pure dialysis fluids and sterile substitution fluids at pyrogen-free levels and can be considered microbiologically safe, according to a redundant safety mode of the on-line system by a second filtration step.
Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients
Daniele Marcelli,Inga Bayh,José Ignacio Merello,Pedro Ponce,Alex Heaton,Fatih Kircelli,Charles Chazot,Attilio Di Benedetto,Cristina Marelli,Erzsébet Ladányi,Miroslaw Kroczak,Stefano Stuard,Aileen Grassmann,Laura Scatizzi,Katharina Brand,Bernard Canaud +15 more
TL;DR: The results allow more accurate planning for future clinical trials addressing anemia management in dialysis patients, and a significant advantage in terms of lower ERI for patients treated by HDF was found.
38
Improved Survival of Incident Patients with High-Volume Haemodiafiltration: A Propensity-Matched Cohort Study with Inverse Probability of Censoring Weighting
Bernard Canaud,Inga Bayh,Daniele Marcelli,Pedro Ponce,José Ignacio Merello,Konstantin Gurevich,Erzsébet Ladányi,Ercan Ok,Goran Imamovic,Aileen Grassmann,Laura Scatizzi,Emanuele Gatti +11 more
TL;DR: This large-scale study supports the generalizability of previous RCT findings regarding the survival benefit of HV-HDF and shows that some sub-cohorts appear to benefit more from HV -HDF than others.
21
Analgesic nephropathy in Hungary: the HANS study
István Pintér,János Mátyus,Zoltán Czégány,Judit Harsányi,Marietta Homoki,Kassai M,Éva Kiss,István Kiss,Erzsébet Ladányi,Lajos Locsey,Lajos Major,Mihály Misz,Lajos Nagy,Kálmán Polner,Jeno Rédl,István Solt,Béla Tichy,Marietta Török,Gábor Varga,Gyula Wágner,Imre Wórum,Béla Zsoldos,László Pótó,Katalin Dérczy,István Wittmann,Judit Nagy +25 more
TL;DR: The survey suggested analgesic nephropathy in 47 of 1400 patients (3.3%), 3-fold higher than the EDTA database estimate for Hungary.